{"DataElement":{"publicId":"7550059","version":"1","preferredName":"Pharmacogenomics Findings Domain CD23 Test Outcome","preferredDefinition":"A question that asks for the test outcome of CD23.","longName":"PF_PFORRES_CD23","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7550058","version":"1","preferredName":"Pharmacogenomics Findings Domain Performed CD23 Antigen Biomarker Test Performed","preferredDefinition":"A findings domain for gene expression and genetic variation assessments._Executed and carried through to completion._Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI)._A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention._A procedure for critical evaluation; a means of determining the presence, quality, or truth of something._To execute and carry through to completion.","longName":"6944198v1.0:7550068v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6944198","version":"1","preferredName":"Pharmacogenomics Findings Domain","preferredDefinition":"A findings domain for gene expression and genetic variation assessments.","longName":"C111289","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacogenomics Findings Domain","conceptCode":"C111289","definition":"A findings domain for gene expression and genetic variation assessments.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9365C759-3409-7B96-E053-F662850AD5BA","latestVersionIndicator":"Yes","beginDate":"2019-09-25","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-09-25","modifiedBy":"ONEDATA","dateModified":"2019-09-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7550068","version":"1","preferredName":"CD23 Antigen Biomarker Test Performed","preferredDefinition":"Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI).:A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.:A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.:Executed and carried through to completion.","longName":"C0162826:C16342:C47891:C38000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD23 Antigen","conceptCode":"C0162826","definition":"Specific molecular sites on the surface of B- and T-lymphocytes which combine with IgEs. Two subclasses exist: low affinity receptors (Fc epsilon RII) and high affinity receptors (Fc epsilon RI).","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"3"},{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Test","conceptCode":"C47891","definition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8F57CD3-D5F9-2B23-E053-4EBD850A1301","latestVersionIndicator":"Yes","beginDate":"2021-01-15","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-15","modifiedBy":"ONEDATA","dateModified":"2021-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8F5DEE7-FC41-5C76-E053-4EBD850AAD69","latestVersionIndicator":"Yes","beginDate":"2021-01-15","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-15","modifiedBy":"GALITG","dateModified":"2021-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3764673","version":"1","preferredName":"Cytogenetic Test Outcome","preferredDefinition":"the outcome or result of a cytogenetic procedure.","longName":"CygTtRltOc","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Normal","valueDescription":"Normal","ValueMeaning":{"publicId":"2567281","version":"1","preferredName":"Normal","longName":"2567281","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3DE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD3FAD6E-A647-CD9F-E040-BB89AD4333D3","beginDate":"2013-05-16","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-21","modifiedBy":"ONEDATA","dateModified":"2013-05-21","deletedIndicator":"No"},{"value":"Abnormal","valueDescription":"Abnormal","ValueMeaning":{"publicId":"2562119","version":"1","preferredName":"Abnormal","longName":"2562119","preferredDefinition":"Deviating from the norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BFB4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-07-22","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-22","modifiedBy":"REEVESD","dateModified":"2010-07-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD3FAD6E-A651-CD9F-E040-BB89AD4333D3","beginDate":"2013-05-16","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-21","modifiedBy":"ONEDATA","dateModified":"2013-05-21","deletedIndicator":"No"},{"value":"Normal G-banding with abnormal FISH","valueDescription":"Normal G-banding with abnormal FISH","ValueMeaning":{"publicId":"3769180","version":"1","preferredName":"Normal G-banding with abnormal FISH","longName":"3769180","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI): Use of Giemsa stain to produce a characteristic staining pattern on chromosomes: Used to indicate the presence of something or someone.: Deviating from the norm.: A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"G-Banding","conceptCode":"C19478","definition":"Use of Giemsa stain to produce a characteristic staining pattern on chromosomes","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DD3FAD6E-A6A4-CD9F-E040-BB89AD4333D3","latestVersionIndicator":"Yes","beginDate":"2013-05-21","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD3FAD6E-A6BD-CD9F-E040-BB89AD4333D3","beginDate":"2013-05-21","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-21","modifiedBy":"ONEDATA","dateModified":"2013-05-21","deletedIndicator":"No"},{"value":"Insufficient G-banding with normal FISH","valueDescription":"Insufficient G-banding with normal FISH","ValueMeaning":{"publicId":"3764675","version":"1","preferredName":"Insufficient G-banding with normal FISH","longName":"3764675","preferredDefinition":"Not meeting a quantitative or qualitative measure necessary for a requirement.: Use of Giemsa stain to produce a characteristic staining pattern on chromosomes: Used to indicate the presence of something or someone.: Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm. (NCI): A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inadequate","conceptCode":"C69177","definition":"Not meeting a quantitative or qualitative measure necessary for a requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"G-Banding","conceptCode":"C19478","definition":"Use of Giemsa stain to produce a characteristic staining pattern on chromosomes","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCDBFF5A-F83D-E466-E040-BB89AD4375DA","latestVersionIndicator":"Yes","beginDate":"2013-05-16","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD3FAD6E-A6D1-CD9F-E040-BB89AD4333D3","beginDate":"2013-05-16","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-21","modifiedBy":"ONEDATA","dateModified":"2013-05-21","deletedIndicator":"No"},{"value":"Insufficient G-banding with abnormal FISH","valueDescription":"Insufficient G-banding with abnormal FISH","ValueMeaning":{"publicId":"3765507","version":"1","preferredName":"Insufficient G-banding with abnormal FISH","longName":"3765507","preferredDefinition":"Not meeting a quantitative or qualitative measure necessary for a requirement.: Use of Giemsa stain to produce a characteristic staining pattern on chromosomes: Used to indicate the presence of something or someone.: Deviating from the norm.: A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inadequate","conceptCode":"C69177","definition":"Not meeting a quantitative or qualitative measure necessary for a requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"G-Banding","conceptCode":"C19478","definition":"Use of Giemsa stain to produce a characteristic staining pattern on chromosomes","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Abnormal","conceptCode":"C25401","definition":"Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCDBFF5A-F8B9-E466-E040-BB89AD4375DA","latestVersionIndicator":"Yes","beginDate":"2013-05-16","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD3FAD6E-A6E5-CD9F-E040-BB89AD4333D3","beginDate":"2013-05-16","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-21","modifiedBy":"ONEDATA","dateModified":"2013-05-21","deletedIndicator":"No"},{"value":"Insufficient G-banding with Insufficient FISH","valueDescription":"Insufficient G-banding with Insufficient FISH","ValueMeaning":{"publicId":"3765506","version":"1","preferredName":"Insufficient G-banding with Insufficient FISH","longName":"3765506","preferredDefinition":"Not meeting a quantitative or qualitative measure necessary for a requirement.: Use of Giemsa stain to produce a characteristic staining pattern on chromosomes: Used to indicate the presence of something or someone.: Not meeting a quantitative or qualitative measure necessary for a requirement.: A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Inadequate","conceptCode":"C69177","definition":"Not meeting a quantitative or qualitative measure necessary for a requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"G-Banding","conceptCode":"C19478","definition":"Use of Giemsa stain to produce a characteristic staining pattern on chromosomes","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"With","conceptCode":"C62355","definition":"Used to indicate the presence of something or someone.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Inadequate","conceptCode":"C69177","definition":"Not meeting a quantitative or qualitative measure necessary for a requirement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCDBFF5A-F890-E466-E040-BB89AD4375DA","latestVersionIndicator":"Yes","beginDate":"2013-05-16","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DD3FAD6E-A6F9-CD9F-E040-BB89AD4333D3","beginDate":"2013-05-16","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-21","modifiedBy":"ONEDATA","dateModified":"2013-05-21","deletedIndicator":"No"},{"value":"Not done","valueDescription":"Not Done","ValueMeaning":{"publicId":"2568055","version":"1","preferredName":"Not Done","longName":"2568055","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or not been completed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D6E4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-01-12","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-01-12","modifiedBy":"REEVESD","dateModified":"2014-04-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E8DF14C6-F6CC-FCFD-E040-BB89AD435F6E","beginDate":"2013-10-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-10-16","modifiedBy":"ONEDATA","dateModified":"2013-10-16","deletedIndicator":"No"},{"value":"Insufficient cells","valueDescription":"Insufficient cells","ValueMeaning":{"publicId":"3921132","version":"1","preferredName":"Insufficient cells","longName":"3921132","preferredDefinition":"Insufficient cells","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8DF14C6-F6D6-FCFD-E040-BB89AD435F6E","latestVersionIndicator":"Yes","beginDate":"2013-10-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-10-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E8DF14C6-F6EF-FCFD-E040-BB89AD435F6E","beginDate":"2013-10-16","endDate":null,"createdBy":"ZIEGLERK","dateCreated":"2013-10-16","modifiedBy":"ONEDATA","dateModified":"2013-10-16","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"19D59F96-8C3D-9D28-E050-BB89AD437C65","beginDate":"2015-07-01","endDate":null,"createdBy":"LEEW","dateCreated":"2015-07-01","modifiedBy":"ONEDATA","dateModified":"2015-07-01","deletedIndicator":"No"},{"value":"Normal (Down syndrome)","valueDescription":"Normal (Down syndrome)","ValueMeaning":{"publicId":"4852411","version":"1","preferredName":"Normal (Down syndrome)","longName":"4852411","preferredDefinition":"Normal (Down syndrome)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17B74B5D-8179-E3E1-E050-BB89AD430AC0","latestVersionIndicator":"Yes","beginDate":"2015-06-04","endDate":null,"createdBy":"LEEW","dateCreated":"2015-06-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17B74B5D-8192-E3E1-E050-BB89AD430AC0","beginDate":"2015-06-04","endDate":null,"createdBy":"LEEW","dateCreated":"2015-06-04","modifiedBy":"ONEDATA","dateModified":"2015-06-04","deletedIndicator":"No"},{"value":"Normal","valueDescription":"Normal","ValueMeaning":{"publicId":"3204402","version":"1","preferredName":"Normal","longName":"3204402","preferredDefinition":"Normal","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9EA0018A-81CF-5CC9-E040-BB89AD43630E","latestVersionIndicator":"Yes","beginDate":"2011-03-16","endDate":null,"createdBy":"LUY","dateCreated":"2011-03-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"25DEA8D5-2F44-5AE8-E050-BB89AD437F81","beginDate":"2015-12-01","endDate":null,"createdBy":"MIRANDAA","dateCreated":"2015-12-01","modifiedBy":"ONEDATA","dateModified":"2015-12-01","deletedIndicator":"No"},{"value":"Normal G-banding and normal FISH","valueDescription":"Normal G-banding and normal FISH","ValueMeaning":{"publicId":"7148826","version":"1","preferredName":"Normal G-banding and normal FISH","longName":"7148826","preferredDefinition":"Normal G-banding and normal FISH","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD29082-E838-42D5-E053-F662850AF5DC","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"LEEW","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9CD29082-E851-42D5-E053-F662850AF5DC","beginDate":"2020-01-23","endDate":null,"createdBy":"LEEW","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","deletedIndicator":"No"},{"value":"Normal G-banding and abnormal FISH","valueDescription":"Normal G-banding and abnormal FISH","ValueMeaning":{"publicId":"7148849","version":"1","preferredName":"Normal G-banding and abnormal FISH","longName":"7148849","preferredDefinition":"Normal G-banding and abnormal FISH","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD36448-2E0F-7CF9-E053-F662850A9AA8","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"LEEW","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9CD36448-2E28-7CF9-E053-F662850A9AA8","beginDate":"2020-01-23","endDate":null,"createdBy":"LEEW","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","deletedIndicator":"No"},{"value":"Abnormal G-banding and normal FISH","valueDescription":"Abnormal G-banding and normal FISH","ValueMeaning":{"publicId":"7148824","version":"1","preferredName":"Abnormal G-banding and normal FISH","longName":"7148824","preferredDefinition":"Abnormal G-banding and normal FISH","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD4F88F-4EE8-42C9-E053-F662850A8D6D","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"LEEW","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9CD4F88F-4F01-42C9-E053-F662850A8D6D","beginDate":"2020-01-23","endDate":null,"createdBy":"LEEW","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","deletedIndicator":"No"},{"value":"Abnormal G-banding and abnormal FISH","valueDescription":"Abnormal G-banding and abnormal FISH","ValueMeaning":{"publicId":"7148825","version":"1","preferredName":"Abnormal G-banding and abnormal FISH","longName":"7148825","preferredDefinition":"Abnormal G-banding and abnormal FISH","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9CD4F88F-4F0B-42C9-E053-F662850A8D6D","latestVersionIndicator":"Yes","beginDate":"2020-01-23","endDate":null,"createdBy":"LEEW","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9CD4F88F-4F26-42C9-E053-F662850A8D6D","beginDate":"2020-01-23","endDate":null,"createdBy":"LEEW","dateCreated":"2020-01-23","modifiedBy":"ONEDATA","dateModified":"2020-01-23","deletedIndicator":"No"},{"value":"Not Performed","valueDescription":"Negation Performed","ValueMeaning":{"publicId":"2783448","version":"1","preferredName":"Negation Performed","longName":"2783448","preferredDefinition":"Executed and carried through to completion.:An operation in which a term denies or inverts the meaning of another term or construction.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Performed","conceptCode":"C38000","definition":"Executed and carried through to completion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56934A15-43E5-2A2F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-10","endDate":null,"createdBy":"UMLLOADER_CATISSUE","dateCreated":"2008-09-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E7814C4-A9A8-4F3F-E053-F662850A416A","beginDate":"2020-02-13","endDate":null,"createdBy":"LEEW","dateCreated":"2020-02-13","modifiedBy":"ONEDATA","dateModified":"2020-02-13","deletedIndicator":"No"},{"value":"Negative","valueDescription":"Negative","ValueMeaning":{"publicId":"6272120","version":"1","preferredName":"Negative","longName":"6272120v1.00","preferredDefinition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negative Finding","conceptCode":"C38757","definition":"A finding of normality following an examination or investigation looking for the presence of a microorganism, disease, or condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BBAEF3E-C626-02A7-E053-F662850A4944","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-05-08","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E7814C4-A9B2-4F3F-E053-F662850A416A","beginDate":"2020-02-13","endDate":null,"createdBy":"LEEW","dateCreated":"2020-02-13","modifiedBy":"ONEDATA","dateModified":"2020-02-13","deletedIndicator":"No"},{"value":"Positive","valueDescription":"Positive","ValueMeaning":{"publicId":"6272119","version":"1","preferredName":"Positive","longName":"6272119v1.00","preferredDefinition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Finding","conceptCode":"C38758","definition":"A finding of abnormality following an examination or observation confirming something, such as the presence of a disease, condition, or microorganism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BBAEF3E-C603-02A7-E053-F662850A4944","latestVersionIndicator":"Yes","beginDate":"2018-05-08","endDate":null,"createdBy":"KEARNSD","dateCreated":"2018-05-08","modifiedBy":"KUMMEROA","dateModified":"2024-01-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9E7814C4-A9BC-4F3F-E053-F662850A416A","beginDate":"2020-02-13","endDate":null,"createdBy":"LEEW","dateCreated":"2020-02-13","modifiedBy":"ONEDATA","dateModified":"2020-02-13","deletedIndicator":"No"},{"value":"Not evaluable","valueDescription":"Unevaluable","ValueMeaning":{"publicId":"3153578","version":"1","preferredName":"Unevaluable","longName":"3153578","preferredDefinition":"Unable to be evaluated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unevaluable","conceptCode":"C62222","definition":"Unable to be evaluated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93AC689E-5DB2-5D7A-E040-BB89AD430948","latestVersionIndicator":"Yes","beginDate":"2010-10-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-10-28","modifiedBy":"KUMMEROA","dateModified":"2023-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8E782D4-0AA9-0C21-E053-4EBD850A3716","beginDate":"2021-01-14","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-14","modifiedBy":"ONEDATA","dateModified":"2021-01-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2476191","version":"1","preferredName":"Result","preferredDefinition":"Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"11CE3EF3-93C8-1DC4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DCDBFF5A-F823-E466-E040-BB89AD4375DA","latestVersionIndicator":"Yes","beginDate":"2013-05-16","endDate":null,"createdBy":"WONGW","dateCreated":"2013-05-16","modifiedBy":"GALITG","dateModified":"2021-01-14","changeDescription":"Changed from CTEP to COG for by script Thu Jan 2 10:00:57 EST 2014","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CD23","type":"Preferred Question Text","description":"CD23","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8F57CD3-D5CC-2B23-E053-4EBD850A1301","latestVersionIndicator":"Yes","beginDate":"2021-01-15","endDate":null,"createdBy":"GALITG","dateCreated":"2021-01-15","modifiedBy":"GALITG","dateModified":"2021-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}